Crossmark

Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options

Crossref DOI link: https://doi.org/10.1038/nrgastro.2016.126

Published Online: 2016-08-18

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lempp, Florian A.

Ni, Yi

Urban, Stephan
License Information

Text and Data Mining valid from 2016-08-18
More Information

Article History

First Online: 18 August 2016

Competing interests

: S.U. is co-applicant and co-inventor of patents protecting Myrcludex B. S.U. is also a consultant for Gilead and Humabs BioMed SA. F.A.L. and Y.N. declare no competing interests.